Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProQuad IM vs SC in Healthy Children
NCT00402831Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2006
- Primary completion
- May 2007
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in measles, mumps, rubella, varicella (VZV), sponsored by Merck & Co.. Started Oct 2006; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00402831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402831.